COVID-19 vaccination figures more up-to-date due to optimised monitoring RIVM has been publishing national and regional figures on COVID-19 vaccination in the Netherlands every week since 19 January 2021.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.